Tarsus Pharmaceuticals, Inc. (TARS) closed the last trading session at $50.40, gaining 10.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $64 indicates a 27% upside potential.The average comprises eight short-term price targets ranging from a low of $41 to a high of $84, with a standard deviation of $12.83. While the lowest estimate indicates a decline of 18.7% from the current ...